Literature DB >> 9274534

Alterations in cytokeratin expression by the alveolar lining epithelial cells in lung tissues from patients with idiopathic pulmonary fibrosis.

K Iyonaga1, M Miyajima, M Suga, N Saita, M Ando.   

Abstract

It is generally recognized that epithelial cytokeratins (CKs) are expressed in tissue-specific patterns and reflect differentiation, functional specialization, and pathological alterations of the cells. Differential epithelial cell types can thus be distinguished from each other by their selective expression of particular sets of CKs. To determine the characteristics of metaplastic and hyperplastic changes of alveolar-lining epithelial cells in the lungs of idiopathic pulmonary fibrosis (IPF), the expression of individual CKs was studied immunohistochemically using monospecific anti-CK monoclonal antibodies (anti-CKs 7, 8, 10, 13, 14, 16, 17, 18, 19). Biopsy specimens from 17 patients with IPF and normal lung tissues (NL) from seven patients with lung cancer were studied. In the IPF specimens, several kinds of altered epithelial cells were observed, which showed characteristic changes in CK expression compared with NL, especially CKs 8, 14, and 17. Hyperplastic type II cells expressed increased CKs 7, 8, and 19, but not CK 17; flattened or stratified squamous metaplastic cells expressed increased CKs 17 and 14, co-expressed with CKs 7, 8, and 19; bronchiolar metaplastic cells expressed increased CKs 7, 8, and 19, co-expressed with CKs 14 and 17; cuboidal metaplastic cells expressed increased CKs 7, 8, 17, and 19. The quantification of individual CKs in the tissues by enzyme-linked immunosorbent assay revealed increased expression of CKs 8, 14, and 17 in IPF lung tissues compared with NL. These results were consistent with the immunohistochemical observations. The hyperplastic and bronchiolar metaplastic phenotypes were characterized by their increased expression of simple CKs without CK alteration. The squamous metaplastic phenotype showed CK alterations, with the appearance of CKs 17 and 14. Epithelial cells are thus altered not only in shape, but possibly also in differentiation and function, with potential implications for the pathogenesis of IPF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274534     DOI: 10.1002/(SICI)1096-9896(199706)182:2<217::AID-PATH833>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

Review 1.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Tracheal Basal cells: a facultative progenitor cell pool.

Authors:  Brook B Cole; Russell W Smith; Kimberly M Jenkins; Brian B Graham; Paul R Reynolds; Susan D Reynolds
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

3.  Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis.

Authors:  Cecilia Marmai; Rachel E Sutherland; Kevin K Kim; Gregory M Dolganov; Xiaohui Fang; Sophia S Kim; Shuwei Jiang; Jeffery A Golden; Charles W Hoopes; Michael A Matthay; Harold A Chapman; Paul J Wolters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-15       Impact factor: 5.464

Review 4.  Epithelial origin of myofibroblasts during fibrosis in the lung.

Authors:  Brigham C Willis; Roland M duBois; Zea Borok
Journal:  Proc Am Thorac Soc       Date:  2006-06

5.  Cytokeratin 19 fragments in patients with acute lung injury: a preliminary observation.

Authors:  Jean-Baptiste Stern; Catherine Paugam; Pierre Validire; Homa Adle-Biassette; Sandrine Jaffré; Monique Dehoux; Bruno Crestani
Journal:  Intensive Care Med       Date:  2006-03-29       Impact factor: 17.440

6.  Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders.

Authors:  N Dobashi; J Fujita; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Kamei; M Tokuda; S Hojo; H Okada; J Takahara
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

7.  Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis.

Authors:  Brigham C Willis; Janice M Liebler; Katherine Luby-Phelps; Andrew G Nicholson; Edward D Crandall; Roland M du Bois; Zea Borok
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

Review 8.  Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.

Authors:  Eric S White; Michael H Lazar; Victor J Thannickal
Journal:  J Pathol       Date:  2003-11       Impact factor: 7.996

Review 9.  Intermediate filaments of the lung.

Authors:  Hayan Yi; Nam-On Ku
Journal:  Histochem Cell Biol       Date:  2013-06-14       Impact factor: 4.304

10.  Interleukin-13 disrupts type 2 pneumocyte stem cell activity.

Authors:  Kristen M Glisinski; Adam J Schlobohm; Sarah V Paramore; Anastasiya Birukova; M Arthur Moseley; Matthew W Foster; Christina E Barkauskas
Journal:  JCI Insight       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.